Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Vaxneuvance“
Suchtreffer
Begriffe & Kennungen
Vaxneuvance · 4.8 · Adults 18 years of age and older
Eintrag öffnenVaxneuvance · 4.8 · Adverse reactions associated with Vaxneuvance obtained from clinical studies, enrolling participants aged at l
Eintrag öffnenVaxneuvance · 4.8 · Adverse reactions reported for all age groups are listed in this section per system organ class, in decreasing
Eintrag öffnenVaxneuvance · 4.8 · All 5 studies evaluated the safety of Vaxneuvance when administered concomitantly with other routine paediatri
Eintrag öffnenVaxneuvance · 4.8 · Catch-up vaccination schedule Safety was also assessed as a catch-up vaccination schedule in 126 healthy infan
Eintrag öffnenVaxneuvance · 4.8 · Children and adolescents with sickle cell disease or living with HIV Safety was also assessed in 69 children a
Eintrag öffnenVaxneuvance · 4.8 · Children and adults receiving haematopoietic stem cell transplant Safety was also assessed in 131 adults and 8
Eintrag öffnenVaxneuvance · 4.8 · In clinical studies older adults (≥50 years of age) reported lower frequencies of solicited local and systemic
Eintrag öffnenVaxneuvance · 4.8 · Infants and children aged 6 weeks to less than 2 years
Eintrag öffnenVaxneuvance · 4.8 · Mixed dose regimen of different pneumococcal conjugate vaccines The safety profiles of mixed 4-dose regimens o
Eintrag öffnenVaxneuvance · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenVaxneuvance · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenVaxneuvance · 4.8 · Summary of the safety profile
Eintrag öffnenVaxneuvance · 4.8 · System Organ Adverse reactions Frequency Class Infants/Children/Adolescents◊ Adults¶ 6W to <2Y‖ 2 to <18Y§ Imm
Eintrag öffnenVaxneuvance · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenVaxneuvance · 4.8 · The most frequent adverse reactions are injection-site pain (55%), myalgia (24%), injection-site swelling (21%
Eintrag öffnenVaxneuvance · 4.8 · The most frequent adverse reactions are injection-site pain (65%), fatigue (23 %), myalgia (21%), headache (17
Eintrag öffnenVaxneuvance · 4.8 · The most frequent adverse reactions are pyrexia ≥38 °C (75%), irritability (75%), somnolence (55%), injection-
Eintrag öffnenVaxneuvance · 4.8 · The safety of Vaxneuvance in healthy and immunocompetent adults was assessed in 6 clinical studies in 7 136 ad
Eintrag öffnenVaxneuvance · 4.8 · The safety of Vaxneuvance in healthy children and adolescents was assessed in a study that included 352 partic
Eintrag öffnen